Q3 2016 Holdings
Filed 2016-11-14 | 24 holdings | $17.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $8.2M | 305,505 | 47.9% |
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $4.4M | 1,005,104 | 25.9% |
| Ascendis Pharma A/S(ASND) | COM | 04351P101 | $1.8M | 90,000 | 10.6% |
| BeiGene Ltd(ONC) | COM | 07725L102 | $1.6M | 51,000 | 9.2% |
| CytomX Therapeutics Inc(CTMX) | COM | 23284F105 | $1.0M | 64,200 | 5.9% |
| DBV Technologies | COM | F2927N109 | $32.5K | 456,893 | 0.2% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $18.9K | 1,095,734 | 0.1% |
| Flamel Technologies S.A. | COM | 338488109 | $6.2K | 500,000 | 0.0% |
| Adverum Biotechnologies(ADVMCHF) | COM | 00773U108 | $4.5K | 1,102,735 | 0.0% |
| Lipocine Inc | COM | 53630X104 | $3.8K | 849,921 | 0.0% |
| CoLucid Pharmaceuticals | COM | 19716T101 | $2.6K | 68,190 | 0.0% |
| Axovant Sciences Ltd | COM | G0750W104 | $2.6K | 184,110 | 0.0% |
| Ocera Therapeutics | COM | 67552A108 | $2.3K | 856,550 | 0.0% |
| Zafgen Inc | COM | 98885E103 | $2.0K | 602,114 | 0.0% |
| Alcobra Ltd | COM | M2239P109 | $1.6K | 658,910 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $1.5K | 135,420 | 0.0% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $1.5K | 180,000 | 0.0% |
| Edge Therapeutics Inc | COM | 279870109 | $1.4K | 135,000 | 0.0% |
| Akari Therapeutics Plc | COM | 00972G108 | $1.3K | 158,352 | 0.0% |
| Arca biopharma Inc | COM | 00211Y100 | $1.3K | 462,399 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $337 | 24,089 | 0.0% |
| Audentes Therapeutics(BOLDEUR) | COM | 05070R104 | $267 | 15,000 | 0.0% |
| ProNAI Therapeutics Inc | COM | 74346L101 | $102 | 56,056 | 0.0% |
| Aeglea BioTherapeutics(AGLEUSD) | COM | 00773J103 | $38 | 6,000 | 0.0% |